AIG
SBBP

American International Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

American International Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25,659
Closed -$71 – 3374
2021
Q1 		$71 Buy
25,659
+68
+0.3% +$205 ﹤0.01% 2873
2020
Q4 		$62 Buy
25,591
+4,352
+20% +$10.5K ﹤0.01% 2892
2020
Q3 		$45K Sell
21,239
-482
-2% -$1.63K ﹤0.01% 2917
2020
Q2 		$82K Buy
21,721
+297
+1% +$890 ﹤0.01% 2656
2020
Q1 		$40K Sell
21,424
-1,238
-5% -$3.22K ﹤0.01% 2770
2019
Q4 		$47K Sell
22,662
-191
-0.8% -$366 ﹤0.01% 2901
2019
Q3 		$55K Sell
22,853
-159
-0.7% -$427 ﹤0.01% 2877
2019
Q2 		$72K Buy
+23,012
New +$84.5K ﹤0.01% 2842
2018
Q2 		– Sell
-17,911
Closed -$159K – 3148
2018
Q1 		$159K Buy
17,911
+1,271
+8% +$9.52K ﹤0.01% 2397
2017
Q4 		$121K Buy
16,640
+1,943
+13% +$12.1K ﹤0.01% 2635
2017
Q3 		$101K Buy
14,697
+1,098
+8% +$7.58K ﹤0.01% 2656
2017
Q2 		$97K Buy
+13,599
New +$62.9K ﹤0.01% 2749

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

American International Group's SBBP Position: Q2 2021 in Review

American International Group sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 25,659 shares — an estimated $71 sold.

American International Group first reported a position in SBBP in Q2 2017 and held it in 12 quarters. The position peaked at $159K in Q1 2018. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • American International Group reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 25,659 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $71.
  • American International Group first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 12 quarters.
  • American International Group's Strongbridge Biopharma plc. position peaked at $159K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.